[go: up one dir, main page]

GB0112342D0 - Polypeptides - Google Patents

Polypeptides

Info

Publication number
GB0112342D0
GB0112342D0 GBGB0112342.1A GB0112342A GB0112342D0 GB 0112342 D0 GB0112342 D0 GB 0112342D0 GB 0112342 A GB0112342 A GB 0112342A GB 0112342 D0 GB0112342 D0 GB 0112342D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0112342.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Priority to GBGB0112342.1A priority Critical patent/GB0112342D0/en
Publication of GB0112342D0 publication Critical patent/GB0112342D0/en
Priority to PCT/NO2002/000176 priority patent/WO2002094312A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/10Cellular immunotherapy characterised by the cell type used
    • A61K40/11T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00Cellular immunotherapy
    • A61K40/40Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41Vertebrate antigens
    • A61K40/42Cancer antigens
    • A61K40/4244Enzymes
    • A61K40/4246Telomerase or [telomerase reverse transcriptase [TERT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0112342.1A 2001-05-21 2001-05-21 Polypeptides Ceased GB0112342D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0112342.1A GB0112342D0 (en) 2001-05-21 2001-05-21 Polypeptides
PCT/NO2002/000176 WO2002094312A1 (en) 2001-05-21 2002-05-16 Polypeptides derived from human telomerase reverse transcriptase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0112342.1A GB0112342D0 (en) 2001-05-21 2001-05-21 Polypeptides

Publications (1)

Publication Number Publication Date
GB0112342D0 true GB0112342D0 (en) 2001-07-11

Family

ID=9915009

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0112342.1A Ceased GB0112342D0 (en) 2001-05-21 2001-05-21 Polypeptides

Country Status (2)

Country Link
GB (1) GB0112342D0 (en)
WO (1) WO2002094312A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1601684B1 (en) * 2003-03-05 2014-10-15 Dendreon Corporation Alternative reading frame polypeptides for treatment
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
LT2536830T (en) 2010-02-16 2019-11-11 Ultimovacs Asa POLYPEPTIDIDES
EP2636752A1 (en) * 2012-03-06 2013-09-11 Universiteit Maastricht In vitro method for determining disease outcome in pulmonary carcinoids.
CN104768967B (en) * 2012-09-19 2019-02-15 珍白斯凯尔有限公司 Cell-penetrating peptides, conjugates comprising the peptides, and compositions comprising the conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291231B (en) * 1996-10-01 2010-06-02 杰龙公司 human telomerase catalytic subunit
JP2002514928A (en) * 1997-07-01 2002-05-21 キャンビア バイオシステムス リミティド ライアビリティー カンパニー Vertebrate telomerase genes and proteins and uses thereof
US7030211B1 (en) * 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase

Also Published As

Publication number Publication date
WO2002094312A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
GB0130557D0 (en) Proteins
GB0130720D0 (en) Proteins
GB0100196D0 (en) Peptides
EP1412499A4 (en) Cytokine polypeptides
AU2002359464A8 (en) Angiopioetin related factors
AU2002241899A1 (en) Tip39 polypeptides
GB0112342D0 (en) Polypeptides
GB0109438D0 (en) Peptides
GB0103517D0 (en) Polypeptide
GB0018307D0 (en) Polypeptides
GB0125636D0 (en) Oligomeric polypeptides
EP1373306A4 (en) Cytoskeletion-associated proteins
GB0105063D0 (en) Polypeptides
GB0113257D0 (en) Polypeptides
GB0101739D0 (en) Novel polypeptide
GB0130560D0 (en) Proteins
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0108218D0 (en) New polypeptide
GB0021685D0 (en) Polypeptides
GB0018908D0 (en) Polypeptides
GB0008945D0 (en) Polypeptides
GB0111031D0 (en) Novel polypeptide
GB0107394D0 (en) Novel polypeptide
GB0104118D0 (en) Novel polypeptide
GB0101222D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)